{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T10:52:04Z","timestamp":1760266324766,"version":"3.41.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2002,9,1]],"date-time":"2002-09-01T00:00:00Z","timestamp":1030838400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2002,9,1]],"date-time":"2002-09-01T00:00:00Z","timestamp":1030838400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2002,9]]},"DOI":"10.1023\/a:1019608404378","type":"journal-article","created":{"date-parts":[[2003,3,13]],"date-time":"2003-03-13T23:26:27Z","timestamp":1047597987000},"page":"157-163","source":"Crossref","is-referenced-by-count":22,"title":["Salvage Chemotherapy with CPT-11 for Recurrent Oligodendrogliomas"],"prefix":"10.1007","volume":"59","author":[{"given":"Marc C.","family":"Chamberlain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"5091060_CR1","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1227\/00006123-199412000-00003","volume":"35","author":"P Calli","year":"1994","unstructured":"Calli P, Nofrone I, Palma L Cantore G, Fortuna A: Cerebral oligodendrogliomas: prognostic factors and life history. Neurosurgery 35: 1018\u20131035, 1994","journal-title":"Neurosurgery"},{"key":"5091060_CR2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1023\/A:1005707203596","volume":"34","author":"C Daumas-Duport","year":"1997","unstructured":"Daumas-Duport C, Varlet P, Tucker ML, Beuvon F, Cervera P, Chodkiewicz JP: Oligodendrogliomas. Part I: Patterns of growth, histological diagnosis, clinical and imaging correlations: A study of 153 cases. J Neuro-Oncol 34: 37\u201359, 1997","journal-title":"J Neuro-Oncol"},{"issue":"2","key":"5091060_CR3","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1056\/NEJM200101113440207","volume":"344","author":"LM DeAngelis","year":"2001","unstructured":"DeAngelis LM: Brain tumors. NEJM 344(2): 114\u2013123, 2001","journal-title":"NEJM"},{"key":"5091060_CR4","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3171\/jns.1987.67.2.0224","volume":"67","author":"KF Lindegaard","year":"1987","unstructured":"Lindegaard KF, Mork SJ, Eide GE, Halvorsen TB, Hatlevoll R, Solgaard T, Dahl O, Ganz J: Statistical analysis of clinicopathological features, radiotherapy, and survival in 170 cases of oligodendroglioma. J Neurosurg 67: 224\u2013230, 1987","journal-title":"J Neurosurg"},{"key":"5091060_CR5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/ana.410190104","volume":"19","author":"CL Ludwig","year":"1986","unstructured":"Ludwig CL, Smith MT, Godfrey AD, Armbrustmacher VW: A clinicopathological study of 323 patients with oligodendrogliomas. Ann Neurol 19: 15\u201321, 1986","journal-title":"Ann Neurol"},{"key":"5091060_CR6","first-page":"59","volume":"3","author":"NA Paleologos","year":"2001","unstructured":"Paleologos NA: Oligodendroglioma. J Neurol 3: 59\u201366, 2001","journal-title":"J Neurol"},{"key":"5091060_CR7","doi-asserted-by":"crossref","first-page":"428","DOI":"10.3171\/jns.1992.76.3.0428","volume":"76","author":"EG Shaw","year":"1992","unstructured":"Shaw EG, Scheithauer BW, O'Fallon JR, Tazelaar HD, Davis DH: Oligodendrogliomas: the Mayo Clinic experience. J Neurosurg 76: 428\u2013434, 1992","journal-title":"J Neurosurg"},{"key":"5091060_CR8","doi-asserted-by":"crossref","first-page":"684","DOI":"10.3171\/jns.1988.68.5.0684","volume":"68","author":"KE Wallner","year":"1988","unstructured":"Wallner KE, Gonzales M, Sheline GE: Treatment of oligodendrogliomas with or without postoperative irradiation. J Neurosurg 68: 684\u2013688, 1988","journal-title":"J Neurosurg"},{"key":"5091060_CR9","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1200\/JCO.1997.15.4.1294","volume":"15","author":"G Leighton","year":"1997","unstructured":"Leighton G, Fisher B, Bauman G, Depiero S, Stitt L, Macdonald D, Cairncross G: Supratentorial low-grade glioma in adults: an analysis of prognostic factors and timing of radiation. J Clin Oncol 15: 1294\u20131301, 1997","journal-title":"J Clin Oncol"},{"issue":"Suppl1","key":"5091060_CR10","first-page":"397","volume":"40","author":"M Brown","year":"1990","unstructured":"Brown M, Durham NC, Cairncross JG et al.: Differential response of recurrent oligodendrogliomas vs. astrocytomas to intravenous (IV) melphalan. Neurology 40(Suppl 1): 397, 1990 (Abstract)","journal-title":"Neurology"},{"key":"5091060_CR11","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1001\/archneur.1991.00530140123026","volume":"78","author":"JG Cairncross","year":"1991","unstructured":"Cairncross JG, Macdonald DR: Chemotherapy for oligodendroglioma. Arch Neurol 78: 225\u2013227, 1991","journal-title":"Arch Neurol"},{"key":"5091060_CR12","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1200\/JCO.1997.15.12.3427","volume":"15","author":"MC Chamberlain","year":"1997","unstructured":"Chamberlain MC, Kormanik PA: Salvage chemotherapy with Paclitaxel for recurrent oligodendrogliomas. J Clin Oncol 15: 3427\u20133432, 1997","journal-title":"J Clin Oncol"},{"key":"5091060_CR13","first-page":"256","volume":"2","author":"O Chinot","year":"2000","unstructured":"Chinot O, Honore S, Barrie M, Dufour H, Brauger D, Grisoli F: Temodal (Temozolomide, TMZ) as secondline treatment following PCV in oligodendroglial tumors. Neuro-Oncol 2: 256, 2000 (Abstract)","journal-title":"Neuro-Oncol"},{"key":"5091060_CR14","doi-asserted-by":"crossref","first-page":"741","DOI":"10.3171\/jns.1992.76.5.0741","volume":"76","author":"J Glass","year":"1992","unstructured":"Glass J, Hochberg FH, Gruber ML, Louis DN, Smith D, Rattner B: The treatment of oligodendrogliomas and mixed oligodendrogliomas astrocytomas with PCV chemotherapy. J Neurosurg 76: 741\u2013745, 1992","journal-title":"J Neurosurg"},{"key":"5091060_CR15","first-page":"176","volume":"8","author":"VA Levin","year":"1996","unstructured":"Levin VA: Controversies in the treatment of low-grade astrocytomas and oligodendrogliomas. Curr Opin Oncol 8: 176\u2013177, 1996","journal-title":"Curr Opin Oncol"},{"key":"5091060_CR16","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1212\/WNL.46.1.203","volume":"46","author":"WP Mason","year":"1996","unstructured":"Mason WP, Krol GS, DeAngelis LM: Low-grade oligodendroglioma responds to chemotherapy. Neurology 46: 203\u2013207, 1996","journal-title":"Neurology"},{"key":"5091060_CR17","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1212\/WNL.54.7.1442","volume":"54","author":"JD Olson","year":"2000","unstructured":"Olson JD, Riedel E, DeAngelis LM: Long-term outcome of low-grade oligodendroglioma and mixed glioma. Neurology 54: 1442\u20131448, 2000","journal-title":"Neurology"},{"key":"5091060_CR18","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1215\/15228517-1-1-61","volume":"1","author":"NA Paleologos","year":"1999","unstructured":"Paleologos NA, Cairncross JG: Treatment of oligodendroglioma: an update. Neuro-Oncol 1: 61\u201368, 1999","journal-title":"Neuro-Oncol"},{"key":"5091060_CR19","first-page":"294","volume":"36","author":"NA Paleologos","year":"1994","unstructured":"Paleologos NA, Vick NA, Kachoris JP: Chemotherapy for low-grade oligodendrogliomas? Ann Neurol 36: 294\u2013295, 1994","journal-title":"Ann Neurol"},{"key":"5091060_CR20","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1001\/archneur.56.4.434","volume":"56","author":"JR Perry","year":"1999","unstructured":"Perry JR, Louis DN, Cairncross JG: Current treatment of oligodendrogliomas. Arch Neurol 56: 434\u2013437, 1999","journal-title":"Arch Neurol"},{"key":"5091060_CR21","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3171\/jns.1996.85.4.0597","volume":"85","author":"K Peterson","year":"1996","unstructured":"Peterson K, Paleologos N, Forsyth P, Macdonald DR, Cairncross JG: Salvage chemotherapy for oligodendroglioma. J Neurosurg 85: 597\u2013601, 1996","journal-title":"J Neurosurg"},{"key":"5091060_CR22","first-page":"298","volume":"2","author":"MJ van den Bent","year":"2000","unstructured":"van den Bent MJ, Eskes FALM, Keime-Guibert F, van den Bent MJ, Boogerd W, Bravo-Marques J, Taphoorn MJB, Kros JM, van de Rijt CDD, de Beule N, Baron B: Temozolomide chemotherapy in recurrent oligodendroglioma. Neuro-Oncol 2: 298, 2000 (Abstract)","journal-title":"Neuro-Oncol"},{"key":"5091060_CR23","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1212\/WNL.51.4.1140","volume":"51","author":"MJ van den Bent","year":"1998","unstructured":"van den Bent MJ, Kros JM, Heimans JJ, Pronk LC, van Groeningen CJ, Krouwer HGJ, Taphoorn MJB, Zonnenberg BA, Tijssen CC, Twijnstra A, Punt CJA, Boogerd W: Response rate and prognostic factors of recurrent oligodendroglioma treated with procarbazine, CCNU, and vincristine chemotherapy. Neurology 51: 1140\u20131145, 1998","journal-title":"Neurology"},{"key":"5091060_CR24","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1227\/00006123-199409000-00004","volume":"35","author":"RC Rostomily","year":"1994","unstructured":"Rostomily RC, Spence AM, Duong D: Multi-modality management of recurrent adult malignant gliomas: results of a phase 2 multi-agent chemotherapy study and analysis of cytoreductive surgery. Neurosurgery 35: 378\u2013388, 1994","journal-title":"Neurosurgery"},{"key":"5091060_CR25","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0733-8619(18)31012-0","volume":"3","author":"M Salcman","year":"1985","unstructured":"Salcman M: Resection and re-operation in neuro-oncology: rationale and approach. Neurol Clin 3: 831\u2013842, 1985","journal-title":"Neurol Clin"},{"key":"5091060_CR26","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1200\/JCO.1995.13.7.1642","volume":"13","author":"WA Hall","year":"1995","unstructured":"Hall WA, Djalilian HR, Sperduto PW, Cho KH, Gerbi BJ, Gibbons JP, Rohr M, Clark HB: Stereotactic radiosurgery for recurrent malignant gliomas. J Clin Oncol 13: 1642\u20131648, 1995","journal-title":"J Clin Oncol"},{"key":"5091060_CR27","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1093\/jnci\/90.19.1473","volume":"90","author":"JG Cairncross","year":"1998","unstructured":"Cairncross JG, Ueki K, Zlatesou MC, Lisle DK, Finkelstein DM, Hammond RR, Silver JS, Stark PC, Macdonald DR, Ino Y, Ramsay DA, Louis DN: Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 90: 1473\u20131479, 1998","journal-title":"J Natl Cancer Inst"},{"key":"5091060_CR28","doi-asserted-by":"crossref","unstructured":"Bauman GS, Ino Y, Ueki M, Zlatescu MC, Fisher BJ, Macdonald DR, Stitt L, Louis DN, Cairncross JG: Allelic loss of chromosome 1p and radiotherapy plus chemotherapy in patients with oligodendroglioma. J Radiation Oncol 48(Suppl 1): 2000 (Abstract)","DOI":"10.1016\/S0360-3016(00)80194-7"},{"issue":"2","key":"5091060_CR29","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0360-3016(90)90096-3","volume":"18","author":"VA Levin","year":"1990","unstructured":"Levin VA, Silver P, Hannigan J, Wara WM, Gutin PH, Davis RL, Wilson CB: Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report. Int J Radiat Oncol Biol Phys 18(2): 321\u2013324, 1990","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5091060_CR30","first-page":"2585","volume":"6","author":"HS Friedman","year":"2000","unstructured":"Friedman HS, Kerby T, Calvert H: Temozolomide and treatment of malignant glioma. Clin Cancer Res 6: 2585\u20132597, 2000","journal-title":"Clin Cancer Res"},{"issue":"7","key":"5091060_CR31","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1200\/JCO.1990.8.7.1277","volume":"8","author":"DR Macdonald","year":"1990","unstructured":"Macdonald DR, Cascino TL, Schold Jr SC, Cairncross JG: Response criteria for Phase II studies supratentorial malignant glioma. J Clin Oncol 8(7): 1277\u20131280, 1990","journal-title":"J Clin Oncol"},{"key":"5091060_CR32","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/0021-9681(61)90060-1","volume":"13","author":"EA Gehan","year":"1961","unstructured":"Gehan EA: The determination of the number of newpatients required in a preliminary and follow-up trial of a new chemotherapeutic agent. J Chronic Dis 13: 346\u2013353, 1961","journal-title":"J Chronic Dis"},{"key":"5091060_CR33","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1200\/JCO.2001.19.5.1501","volume":"19","author":"U Vanhoefer","year":"2001","unstructured":"Vanhoefer U, Harstrick A, Achterrath W, Cao S, Seeber S, Rustum YM: Irinotecan in the treatment of colorectal cancer: clinical overview. J Clin Oncol 19: 1501\u20131518, 2001","journal-title":"J Clin Oncol"},{"key":"5091060_CR34","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJM200009283431302","volume":"343","author":"LB Saltz","year":"2000","unstructured":"Saltz LB, Coz JV, Blanke C, Rosen LS, Fehrenbacher L, Moore MJ, Maroun JA, Ackland SP, Locker PK, Pirotta N, Elfring GL, Miller LL: Irinotecan plus Fluorouracil and Leucovorin for metastatic colorectal cancer. NEJM 343: 905\u2013914, 2000","journal-title":"NEJM"},{"key":"5091060_CR35","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1200\/JCO.1999.17.5.1516","volume":"14","author":"HS Friedman","year":"1999","unstructured":"Friedman HS, Petros WP, Friedman AH, Schaaf LJ, Kerby T, Lawyer J, Parry M, Houghton PJ, Lovell S, Rasheed K, Cloughsey T, Stewart ES, Calvin OM, Provenzale JM, McLendon RE, Bigner DD, Cokgor I, Haglund M, Rich J, Ashley D, Malczyn J, Elfring GL, Miller LL: Irinotecan therapy in adults with recurrent or progressive malignant glioma. J Clin Oncol 14: 1516\u20131525, 1999","journal-title":"J Clin Oncol"},{"key":"5091060_CR36","first-page":"179","volume":"13","author":"MR Fetell","year":"1994","unstructured":"Fetell MR, Grossman SA, Balmaceda C: Clinical and pharmacologic study of preirradiation Taxol administrated as a 96-hour infusion in adults with newly diagnosed glioblastoma multiforme. Proc ASCO 13: 179, 1994 (Abstract)","journal-title":"Proc ASCO"},{"issue":"2","key":"5091060_CR37","first-page":"287","volume":"4","author":"M Prados","year":"2000","unstructured":"Prados M, Kuhn J, Yung WKA, Robbins HI, Fink K, Greenberg H, Junck L, Cloughesy T, Chang S, Fine H, Schiff D, Nicholas MK, Jaeckle KA, Hess K, Wen P: Phase 1\u20132. Study of CPT-11 given every 3 weeks in patients with recurrent brain tumors, a North American Tumor Consortium Study. Neuro-Oncol 4(2): 287\u2013288, 2000 (Abstract)","journal-title":"Neuro-Oncol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1019608404378.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1019608404378\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1019608404378.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T09:00:43Z","timestamp":1749632443000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1019608404378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,9]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,9]]}},"alternative-id":["5091060"],"URL":"https:\/\/doi.org\/10.1023\/a:1019608404378","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"type":"print","value":"0167-594X"},{"type":"electronic","value":"1573-7373"}],"subject":[],"published":{"date-parts":[[2002,9]]}}}